Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C

BACKGROUND: Directly Acting Antivirals (DAAs) are predicted to transform hepatitis C (HCV) therapy, yet little is known about the prevalence of naturally occurring resistance mutations in recently acquired HCV. This study aimed to determine the prevalence and frequency of drug resistance mutations i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antivir Ther
Main Authors: Applegate, Tanya L, Gaudieri, Silvana, Plauzolles, Anne, Chopra, Abha, Grebely, Jason, Lucas, Michaela, Hellard, Margaret, Luciani, Fabio, Dore, Gregory J, Matthews, Gail V
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4320979/
https://ncbi.nlm.nih.gov/pubmed/25105742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP2821
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados